Such normalisation is easier than using surrounding tissue and lowers the inter-individual variability [17]
doi: 10.1016/j.febslet.2014.03.051 47 WangF.YangJ.SunJ.DongY.ZhaoH.ShiH.et al
You can browse the full collection here
Patients may potentially experience significant nausea, diarrhoea, vomiting, or constipation
Standard dosing begins at 0.25 mg weekly for four weeks, increasing to 0.5 mg, then potentially 1 mg or 2 mg weekly depending on response and tolerability
In this article, we will emphasize the role of riboflavin in neuroprotection elaborating on its proposed neuroprotective mechanisms in opposite to the pathogenesis-related mechanisms involved in two common neurological disorders, PD and migraine headache, as well as, we encourage the clinical evaluation of riboflavin in PD and migraine headache patients in the future